Madrigal Pharma explores sale - Bloomberg

June 13 (Reuters) - Madrigal Pharmaceuticals Inc is exploring a sale, Bloomberg reported https://www.bloomberg.com/news/articles/2018-06-13/madrigal-pharma-is-said-to-explore-sale-amid-takeover-interest on Wednesday, citing people familiar with the matter, nearly three weeks after the company reported mid-stage data from its drug to treat non-alcoholic steatohepatitis or NASH.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.